HPCAL1 presented a remarkably poor overall survival (OS) and relapse‐free survival (RFS) probability along with a significant differential expression in CCA (Figure 2B,C), whereas the differential expression trend and RFS probability of CDH6 in CCA were disappointing (Figure 2E,F). The gene discussed is CDH6; the disease is cholangiocarcinoma.